The risk of cardio-cerebral vascular events in type 2 diabetes patients with the usage of saxagliptin
碩士 === 高雄醫學大學 === 藥學系碩士在職專班 === 104 === Background: Saxagliptin is an oral hypoglycemic agent that can control blood sugar by inhibiting the metabolism of incretin. Several research studies recently showed that saxagliptin may increase the risk of cardiovascular events recetently. The aims of our st...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2016
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/40391727183387177674 |